1. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia 
E.V. Lemos, F.P. de la Hoz, N. Alvis, T.R. Einarson, E. Quevedo, C. Castañeda, Y. Leon, C. Amado, O. Cañon, K. Kawai 
Clinical Microbiology and Infection 
Volume 20, Issue 2, Pages (February 2014)
DOI: /
Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
Risk of 30-day mortality comparing patients with carbapenem-resistant Acinetobacter baumannii and patients with carbapenem-susceptible A. baumannii (log rank test, p 0.02).
Clinical Microbiology and Infection  , DOI: ( / )
Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions